Elsevier

Analytica Chimica Acta

Volume 339, Issues 1–2, 28 February 1997, Pages 91-97
Analytica Chimica Acta

Chromatography and other separation technique
A reversed-phase high performance liquid chromatography method using solid phase extraction to quantitate thalidomide in human serum

https://doi.org/10.1016/S0003-2670(96)00494-1Get rights and content

Abstract

Thalidomide, a drug developed in the mid 1950s for sedation and used in the treatment of leprosy for several years, has recently been shown to have anti-angiogenic activity in the rabbit cornea micropocket model. Phase II clinical trials have been initiated in several tumor types, including prostate, brain, breast, and Kaposi's sarcoma. Thus, we developed a high performance liquid chromatography (HPLC) assay to monitor thalidomide serum concentrations. A Hewlett-Packard 1090 Series II Liquid Chromatograph equipped with a photodiode-array detector was used for the Chromatographic analysis. A Waters Nova-Pak C-18 (3.9 × 300 mm) column was used. Thalidomide and phenacetin (internal standard) were detected at UV wavelengths of 220 and 248 nm, respectively, with a run time of 16 min. A gradient mobile phase of water, acetonitrile, and a 0.5 M NaH2PO4 buffer (pH 3.0) was run at a flow rate of 1 ml min−1. Thalidomide was isolated from serum by solid phase extraction. 10% H2SO4 (7.5 μl) was added to the serum to halt degradation. Standard curves were prepared between 50 and 10000 ng ml−1 and linearity was demonstrated in this range of concentrations (r2 = 0.9996 ± 0.0011) (n = 6). Intra-assay and inter-assay imprecision was <4.0% with an error of accuracy of <7.0%. In conclusion, the assay was shown to be reproducible and acceptable for clinical monitoring of thalidomide concentrations in human serum.

References (12)

  • R.L. Barnhill et al.

    J. Am. Acad. Dermatol.

    (1982)
  • T. Eriksson et al.

    J. Chromatogr.

    (1992)
  • A. Lyon et al.

    Clin. Biochem.

    (1995)
  • G.W. Melline et al.

    N. Engl. J. Med.

    (1962)
  • K. Hellman

    Lancet

    (1966)
  • J. Folkman

    N. Engl. J. Med.

    (1971)
There are more references available in the full text version of this article.

Cited by (24)

  • Recent advances in analytical determination of thalidomide and its metabolites

    2008, Journal of Pharmaceutical and Biomedical Analysis
  • Thalidomide enantiomers: Determination in biological samples by HPLC and vancomycin-CSP

    2006, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
View all citing articles on Scopus

This research was funded in part by the US government.

View full text